FDAnews
www.fdanews.com/articles/148737-targeted-drug-slows-thyroid-cancer

Targeted Drug Slows Thyroid Cancer

August 15, 2012
In a small, placebo-controlled study, vandetanib (Caprelsa), a kinase inhibitor, delayed progression of the most common type of thyroid cancer, French researchers reported.
MedPage Today